{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:07:29Z","timestamp":1791191249576,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,27]]},"DOI":"10.1097\/tp.0b013e318244f7b8","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T09:07:39Z","timestamp":1326445659000},"page":"650-656","source":"Crossref","is-referenced-by-count":79,"title":["Late Antibody-Mediated Rejection After Heart Transplantation Following the Development of De Novo Donor-Specific Human Leukocyte Antigen Antibody"],"prefix":"10.1097","volume":"93","author":[{"given":"Aidan M.","family":"Hodges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Lyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene L.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Banner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/qjmed\/hcq205","article-title":". Current outcome of heart transplantation: A 10-year single centre perspective and review.","volume":"104","author":"Hamour","year":"2011","journal-title":"QJM"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":". Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":". Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":". The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R5-14-20210129","first-page":"430","article-title":". Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications.","volume":"8","author":"Hammond","year":"1989","journal-title":"J Heart Transplant"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":". Acute antibody-mediated rejection of cardiac transplants.","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":". Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":". Report from a consensus conference on antibody-mediated rejection in heart transplantation.","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.tp.0000278094.41131.9f","article-title":". The changing pattern of humoral rejection in cardiac transplant recipients.","volume":"84","author":"Almuti","year":"2007","journal-title":"Transplantation"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.healun.2009.04.035","article-title":". Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.","volume":"28","author":"Kfoury","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.transproceed.2006.10.060","article-title":". Effect of plasmapheresis for acute humoral rejection after heart transplantation.","volume":"38","author":"Wang","year":"2006","journal-title":"Transplant Proc"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":". De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.healun.2007.09.011","article-title":". Early screening for antibody-mediated rejection in heart transplant recipients.","volume":"26","author":"Kfoury","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R14-14-20210129","first-page":"S111","article-title":". Vascular rejection and its relationship to allograft coronary artery disease.","volume":"11","author":"Hammond","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"R15-14-20210129","first-page":"S147","article-title":". Vascular rejection in heart transplant recipients.","volume":"12","author":"Miller","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"R16-14-20210129","first-page":"151","article-title":". Clinical-pathologic features of humoral rejection in cardiac allografts: A study in 81 consecutive patients.","volume":"14","author":"Lones","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"R17-14-20210129","first-page":"136","article-title":"Pathologic evaluation for antibody-mediated rejection: Prognostic vs diagnostic markers J Heart Lung T","volume":"30","author":"Rodriguez","year":"2011","journal-title":"ransplant"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOT.0b013e3283352a50","article-title":"Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.","volume":"15","author":"Sis","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":". Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s10875-009-9334-4","article-title":". Immunological challenges of cardiac transplantation: The need for better animal models to answer current clinical questions.","volume":"29","author":"Wehner","year":"2009","journal-title":"J Clin Immunol"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.transproceed.2009.12.060","article-title":". C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.","volume":"42","author":"Arias","year":"2010","journal-title":"Transplant Proc"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1600-6143.2009.02748.x","article-title":". Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection.","volume":"9","author":"Tan","year":"2009","journal-title":"Am J Transplant"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jss.2007.04.023","article-title":". A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection.","volume":"142","author":"Gonzalez-Stawinski","year":"2007","journal-title":"J Surg Res"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2011.01.716","article-title":"; Steering Group, UK Cardiothoracic Transplant Audit. Antithymocyte globulin induction therapy for adult heart transplantation: A UK national study.","volume":"30","author":"Emin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1182\/blood.V83.4.1051.1051","article-title":". Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines.","volume":"83","author":"Bonnefoy-Berard","year":"1994","journal-title":"Blood"},{"key":"R26-14-20210129","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.healun.2003.09.016","article-title":". Effect of late medication non-compliance on outcome after heart transplantation: A 5-year follow-up.","volume":"23","author":"Dobbels","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R27-14-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-6143.2009.02875.x","article-title":". De novo HLA sensitization and antibody mediated rejection following pregnancy in a heart transplant recipient.","volume":"10","author":"OBoyle","year":"2010","journal-title":"Am J Transplant"},{"key":"R28-14-20210129","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1600-6143.2011.03563.x","article-title":". Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy.","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"R29-14-20210129","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).","volume":"29","year":"2008","journal-title":"Eur Heart J"},{"key":"R30-14-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjmed.2010.10.014","article-title":". Venous thromboembolism in heart failure: Preventable deaths during and after hospitalization.","volume":"124","author":"Piazza","year":"2011","journal-title":"Am J Med"},{"key":"R31-14-20210129","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.transproceed.2004.10.087","article-title":". Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.","volume":"36","author":"Baran","year":"2004","journal-title":"Transplant Proc"},{"key":"R32-14-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.healun.2007.01.027","article-title":". Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: Case report and literature review.","volume":"26","author":"Kaczmarek","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R34-14-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0360-3016(95)00135-L","article-title":". Total lymphoid irradiation in the treatment of early or recurrent heart transplant rejection.","volume":"33","author":"Salter","year":"1995","journal-title":"Int Radiat Oncol Biol Phys"},{"key":"R35-14-20210129","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1634\/theoncologist.8-6-508","article-title":". Velcade: US FDA approval for the treatment of multiple myeloma progressing on prior therapy.","volume":"8","author":"Kane","year":"2003","journal-title":"Oncologist"},{"key":"R38-14-20210129","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":". Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R39-14-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/TP.0b013e318168d571","article-title":". Limited utility of endomyocardial biopsy in the first year after heart transplantation.","volume":"85","author":"Hamour","year":"2008","journal-title":"Transplantation"},{"key":"R40-14-20210129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0966-3274(93)90060-L","article-title":". The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation.","volume":"1","author":"Smith","year":"1993","journal-title":"Transpl Immunol"},{"key":"R41-14-20210129","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1600-6143.2007.01991.x","article-title":". C4d fixing, luminex binding antibodiesA new tool for prediction of graft failure after heart transplantation.","volume":"7","author":"Smith","year":"2007","journal-title":"Am J Transplant"},{"key":"R42-14-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.healun.2011.02.015","article-title":". The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011).","volume":"30","author":"Berry","year":"2011","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201203270-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:47:28Z","timestamp":1646236048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201203270-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318244f7b8","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}